Active COVID-19, Clinical Pathway — All Settings
Active COVID-19, Clinical Pathway — All Settings
High Risk Conditions
Pediatric data informing risk stratification to identify children at highest risk of severe disease are limited. The table below summarizes pediatric patients who appear at highest risk for severe disease, particularly if they are unvaccinated or not expected to develop protective immunity from SARS-CoV-2 vaccination due to an immunocompromising condition. We recommend prioritizing these patients for use of COVID-19 therapies.
Category | Specific CHOP Criteria |
---|---|
Primary Immunodeficiency |
|
HIV |
|
Malignancy |
|
Non-malignant Hematologic Disorders |
|
Hematopoietic Stem Cell Transplant |
|
Solid Organ Transplant |
|
Immunosuppressive Medications |
|
Category | Specific CHOP Criteria |
---|---|
Sickle Cell Disease |
|
Severe Pulmonary Disease |
|
Obesity |
|
Severe Cardiac Disease |
|
Diabetes |
|
- 1 Fully vaccinated is defined as an immunocompetent patient > 14 days after the second dose of either mRNA vaccine against COVID-19 OR a single dose of the Johnson and Johnson vaccine